Migraine: preventive treatment

被引:179
|
作者
Silberstein, SD
Goadsby, PJ
机构
[1] Thomas Jefferson Univ Hosp, Jefferson Headache Ctr, Philadelphia, PA 19107 USA
[2] UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, London WC1N 3BG, England
关键词
migraine; prevention; treatment; prophylaxis;
D O I
10.1046/j.1468-2982.2002.00386.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Migraine is a common episodic headache disorder. A comprehensive headache treatment plan includes acute attack treatment to relieve pain and impairment and long-term preventive therapy to reduce attack frequency, severity, and duration. Circumstances that might warrant preventive treatment include: (i) migraine that significantly interferes with the patient's daily routine despite acute treatment; (ii) failure, contraindication to, or troublesome side-effects from acute medications; (iii) overuse of acute medications; (iv) special circumstances, such as hemiplegic migraine; (v) very frequent headaches (more than two a week); or (vi) patient preference. Start the drug at a low dose. Give each treatment an adequate trial. Avoid interfering, overused, and contraindicated drugs. Re-evaluate therapy. Be sure that a woman of childbearing potential is aware of any potential risks. Involve patients in their care to maximize compliance. Consider co-morbidity. Choose a drug based on its proven efficacy, the patient's preferences and headache profile, the drug's side-effects, and the presence or absence of coexisting or co-morbid disease. Drugs that have documented high efficacy and mild to moderate adverse events (AEs) include beta-blockers, amitriptyline, and divalproex. Drugs that have lower documented efficacy and mild to moderate AEs include selective serotonin reuptake inhibitors (SSRIs), calcium channel antagonists, gabapentin, topiramate, riboflavin, and non-steroidal anti-inflammatory drugs.
引用
收藏
页码:491 / 512
页数:22
相关论文
共 50 条
  • [21] RimabotulinumtoxinB for preventive treatment of migraine headaches
    Grogan, P. M.
    Alvarez, M. V.
    [J]. TOXICON, 2013, 68 : 74 - 75
  • [22] Preventive treatment of migraine: effect on weight
    Young, WB
    Rozen, TD
    [J]. CEPHALALGIA, 2005, 25 (01) : 1 - 11
  • [23] Preventive treatment of migraine: Effect on weight
    Young, William B.
    [J]. CURRENT PAIN AND HEADACHE REPORTS, 2008, 12 (03) : 201 - 206
  • [24] Fremanezumab for the preventive treatment of migraine in adults
    Lionetto, Luana
    Curto, Martina
    Cisale, Giusy Ylenia
    Capi, Matilde
    Cipolla, Fabiola
    Guglielmetti, Martina
    Martelletti, Paolo
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 741 - 748
  • [25] Preventive treatment of migraine: Effect on weight
    William B. Young
    [J]. Current Pain and Headache Reports, 2008, 12 : 201 - 206
  • [26] New players in the preventive treatment of migraine
    Dimos D. Mitsikostas
    Alan M. Rapoport
    [J]. BMC Medicine, 13
  • [27] Unmet Needs in Preventive Treatment of Migraine
    Enrico Bentivegna
    Dilara Onan
    Paolo Martelletti
    [J]. Neurology and Therapy, 2023, 12 : 337 - 342
  • [28] THE ROLE OF THE NEUROMODULATORS IN THE PREVENTIVE TREATMENT OF MIGRAINE
    Pascual-Gomez, J.
    [J]. REVISTA DE NEUROLOGIA, 2009, 49 (01) : 25 - 32
  • [29] Fremanezumab for the Preventive Treatment of Chronic Migraine
    Silberstein, Stephen D.
    Dodick, David W.
    Bigal, Marcelo E.
    Yeung, Paul P.
    Goadsby, Peter J.
    Blankenbiller, Tricia
    Grozinski-Wolff, Melissa
    Yang, Ronghua
    Ma, Yuju
    Aycardi, Ernesto
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2113 - 2122
  • [30] Preventive treatment of migraine with amantadine sulphate
    Sobrino, FE
    [J]. CEPHALALGIA, 2005, 25 (08) : 671 - 671